Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Anxiety Disorders 1

Interventions

Blood Specimen Collection 106Standard of Care 82Exercise 68Radiotherapy 53Radiosurgery 47Magnetic Resonance Spectroscopy 46Specimen Handling 45Practice Guidelines as Topic 44Surveys and Questionnaires 43Interviews as Topic 43Educational Status 42Methods 41Drug Therapy 34Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Biopsy 24Control Groups 21venetoclax 17Therapeutics 17Patient Navigation 17Cisplatin 17Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 14Cognitive Behavioral Therapy 13Acupuncture Therapy 13Resistance Training 12Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Glutamyl Aminopeptidase × Clear all
NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting
566 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05475600 2025-03-17

APAER_H

Centre Hospitalier Régional Metz-Thionville

Phase NA Recruiting
90 enrolled
Other hematologic neoplasm

Anxiety Disorders, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡